Exhibit (b)(4)
PROMISSORY NOTE
NEW YORK, N.Y. September 13, 1999
On September 13, 2000 TEVA PHARMACEUTICALS USA, INC. promises to pay to the order of BANK
LEUMI USA ("Bank") the lesser of (x) One Hundred Fifteen Million Dollars ($115,000,000) and (y) the
aggregate unpaid principal amount of all loans made by the Bank to the maker pursuant to the Credit Agreement
dated as of September 13, 1999 among the maker, the Bank and Teva Pharmaceutical Industries Ltd. ("Parent")
at the Bank at 564 Fifth Avenue, New York, New York 10036.
Payment of principal and interest in respect of the indebtedness evidenced by this Note shall be junior and
subordinate and subject in right of payment to specified Senior Debt as provided Addendum A attached hereto.
Interest (shall be computed) at a rate per annum which shall be equal to 1/4% per annum above the Libor Rate
(Reserve Adjusted)* for a one, three or six month term, as elected by the maker and calculated by the Bank, in
the manner hereinafter provided, but in no event in excess of the maximum rate permitted by applicable law;
provided, that in the event the Bank shall have determined that by reason of circumstances affecting the Libor
Rate (Reserve Adjusted) adequate and reasonable means do not exist for ascertaining the Libor Rate (Reserve
Adjusted) for any Interest Period, or the time remaining to the stated maturity date of this Note is less than the
shortest Interest Period which may be elected hereunder, then the applicable
* "Libor Rate" means, relative to any Interest Period (hereinafter defined) for loans made pursuant to this Note
and which bear interest at the "Libor Rate (Reserve Adjusted)", the rate of interest per annum determined by the
Bank to be the arithmetic mean (rounded upward to the next 1/16th of 1%) of the rates of interest per annum at
which dollar deposits in the approximate amount of the amount of the loan to be made or continued hereunder by
the Bank and having a maturity comparable to such Interest Period would be offered to